Cancer and fertility

Organised by the ESHRE Task Force on “Fertility preservation in severe diseases” in co-operation with the National Centre for Tumour Diseases (NCT), Heidelberg

ESHRE Campus meeting

Heidelberg, Germany 14 – 15 November 2008

Syllabus contributions

• Psychological aspects of fertility preservation in life threatening diseases – J. Bitzer (CH)
  
• Ethical aspects of fertility preservation in patients affected by severe disease – G. Pennings (B)
  
• National networks on fertility preservation – a chance to integrate research and clinical approaches – M. von Wolff (D)
  
• Effect of cytotoxic therapies on the ovary – R.A. Anderson (UK)
  
• Effect of cytotoxic therapies on the testis and male fertility – R. Menkveld (ZA)
  
• Crypreservation of sperm and testicular tissue – G. Verheyen (B)
  
• Ovarian transposition before radiation – M. Korell (D)
  
• Fertility preserving treatment of endometrial and cervical cancer – C. Köhler (D)
  
• Fertility preserving therapy of ovarian tumours – S. Gordts (B)
  
• Ovarian tissue freezing – slow freezing versus vitrification – O. Hovatta (S)
  
• Isolation and grafting of isolated human follicles – M.M. Dolmans (B)
  
• Xenotranplantation of human tissue in SCID mice – T. Maltaris (D)
  
• Centralised cryobanks – an option for many countries? – M. Montag (D)
  
• Ovarian stimulation in cancer patiens – T. Strowitzki (D)
  
• Cryopreservation of human oocytes: an overview – S. Al-Hasani (D)
  
• GnRH-a and oral contraceptives: new evidence for a protective effect? – Z. Blumenfeld (IL)
  
• In vitro maturation – O. Hovatta (S)
  
• Combining different techniques – a strategy to increase efficacy? – M. von Wolff (D)
  
• Fertility in young HL patients – K. Behringer (D)
  
• Fertility preservation for children with cancer. Males and females – H. Wallace (UK)
  
• Evaluation of ovarian function – before, during and after chemotherapy.What are the mechanisms of follicular depletion and can we predict ovarian failure? – M. Rosendahl (DK)
  
• Pregnancy after cancer – a genetic risk for the offspring? – M. Bonduelle (B)
  
• Testicular stem cells – S. Schlatt (USA)
  
• Fertility preservation in patients undergoing anti-neoplastic treatment.– D. Denschlag (D)
  
• Uterine transplantation – M. Brännström (S)